Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
20.55
-0.13 (-0.63%)
Aug 11, 2026, 9:56 AM EDT - Market open
Anika Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3.78 | -10.88 | -56.39 | -82.67 | -14.86 | 4.13 |
Depreciation & Amortization | 5.63 | 5.73 | 8.12 | 14.22 | 14.49 | 20.78 |
Stock-Based Compensation | 13.15 | 10.08 | 13.13 | 15.24 | 14.32 | 11.09 |
Other Adjustments | 6.08 | 7.08 | 53.63 | 63.54 | 2.29 | -12.89 |
Change in Receivables | -5.66 | 0.41 | 3.37 | -1.31 | -5.63 | -6.22 |
Changes in Inventories | -13.64 | 0.03 | -9.42 | -11.4 | -6.87 | -6.62 |
Changes in Accounts Payable | 1.28 | 0.04 | -2.51 | -0.01 | 1.97 | -1.1 |
Changes in Accrued Expenses | 2.68 | -1.5 | -3.67 | 1.65 | -0.44 | 3.51 |
Changes in Income Taxes Payable | 1.44 | -0.13 | 0.67 | 0.53 | 1.44 | -1.31 |
Changes in Other Operating Activities | -1.19 | 0.33 | -1.52 | -1.59 | -2.28 | -2.98 |
Operating Cash Flow | 5.98 | 11.19 | 5.4 | -1.79 | 4.41 | 8.4 |
Operating Cash Flow Growth | -4.81% | 107.07% | - | - | -47.49% | -35.73% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -5.42 | -6.83 | -7.73 | -5.43 | -7.49 | -5.14 |
Purchases of Intangible Assets | - | - | -0.6 | - | - | - |
Proceeds from Sale of Intangible Assets | - | 0.6 | - | - | - | - |
Proceeds from Sale of Investments | - | - | - | - | - | 2.5 |
Cash Acquisitions | - | - | - | - | - | -0.48 |
Proceeds from Business Divestments | - | 4.5 | - | - | - | - |
Other Investing Activities | 1.36 | 1.33 | - | - | - | - |
Investing Cash Flow | -4.05 | -0.4 | -8.33 | -5.43 | -7.49 | -3.12 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Issuance of Common Stock | 0.45 | 0.5 | 0.78 | 0.83 | 0.68 | 1.13 |
Repurchase of Common Stock | -16.79 | -11.05 | -13.51 | -7.15 | -0.93 | -0.49 |
Net Common Stock Issued (Repurchased) | -16.34 | -10.55 | -12.73 | -6.32 | -0.25 | 0.64 |
Other Financing Activities | - | - | - | - | -4.6 | -7.42 |
Financing Cash Flow | -16.34 | -10.55 | -12.73 | -6.32 | -4.85 | -6.78 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.34 | 0.09 | -0.05 | 0.08 | -0.13 | 0.07 |
Net Cash Flow | -14.76 | 0.32 | -15.71 | -13.46 | -8.06 | -1.43 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.56 | 4.36 | -2.33 | -7.22 | -3.08 | 3.25 |
Free Cash Flow Growth | - | - | - | - | - | -71.55% |
FCF Margin | 0.47% | 3.87% | -1.94% | -5.97% | -2.70% | 2.20% |
Free Cash Flow Per Share | 0.04 | 0.30 | -0.16 | -0.49 | -0.21 | 0.22 |
Levered Free Cash Flow | -13 | -13.21 | -72.46 | -84.7 | -14.05 | 11.27 |
Unlevered Free Cash Flow | -14.71 | -14.18 | -32.36 | -2.95 | 2.68 | 11.59 |